The DOI matches its Crossref record.
A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn’s Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P., & Quigley, E. M. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.003 · Cited by 837
Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives
Dempsey, E., & Corr, S. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840245 · Cited by 579
The role of the gut microbiome in systemic inflammatory disease
Clemente, J. C., Manasson, J., & Scher, J. U. (2018) · BMJ · doi:10.1136/bmj.j5145 · Cited by 568
Probiotics, gut microbiota and health
Butel, M.-J. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.10.002 · Cited by 457
Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease
Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14203 · Cited by 393
“Most notably, several prior meta-analyses have combined data from trials of probiotics and synbiotics,(28,29,33,36) or pooled data from studies in paediatric and adult populations.(28-30,33,35) Furthermore, only”
BackgroundAntioxidant therapy for treatment of inflammatory bowel disease: Does it work?
Moura, F. A., de Andrade, K. Q., dos Santos, J. C. F., Araújo, O. R. P., & Goulart, M. O. F. (2015) · Redox Biology · doi:10.1016/j.redox.2015.10.006 · Cited by 381
A systematic review of the safety of probiotics
Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.872627 · Cited by 367
Self-citationInflammatory Bowel Disease: An Expanding Global Health Problem
M'koma, A. E. (2013) · Clinical Medicine Insights: Gastroenterology · doi:10.4137/cgast.s12731 · Cited by 359
Ganji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314
“In a meta analysis of 8 trials in 2008, data showed that probiotics, in general, are not more beneficial than placebo and Lactobacillus probiotics were not effective in maintaining remission in patients with CD (Rahimi et al., 2008).”
MethodAn Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
Talley, N. J., Abreu, M. T., Achkar, J.-P., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., Kane, S. V., Sandborn, W. J., Ullman, T. A., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.58 · Cited by 310
DuPont, A., Richards, Jelinek, K. A., Krill, J., Rahimi, E., & Ghouri, Y. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s27530 · Cited by 300
Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis
Hegazy, S. K. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i33.4145 · Cited by 283
New Approaches for Bacteriotherapy: Prebiotics, New-Generation Probiotics, and Synbiotics
Patel, R., & DuPont, H. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ177 · Cited by 267
Yılmaz, İ., Dolar, M. E., & Özpınar, H. (2019) · Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.18227 · Cited by 193
The intestinal microbiota in inflammatory bowel disease
Becker, C., Neurath, M. F., & Wirtz, S. (2015) · ILAR Journal · doi:10.1093/ilar/ilv030 · Cited by 185
Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
Shanahan, F., & Quigley, E. M. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.050 · Cited by 172
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Li, M., Wang, M., & Donovan, S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0033-1361825 · Cited by 131
Metadata
- Authors
- Rahimi, R., Nikfar, S., Rahimi, F., Elahi, B., Derakhshani, S., Vafaie, M., & Abdollahi, M.
- Venue
- Digestive Diseases and Sciences
- Published
- 2008-02-14
- Volume
- 53
- Issue
- 9
- Pages
- 2524-2531
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2055266605
- Cited by
- 173
- References
- 0
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.